Skip to main content
OpenTrials
Completed

NCT Number: NCT02422069

Study of Post Menopausal Osteoporosis (PMO) Among Gynecology Outpatients in Pakistan

This observational study will provide an opportunity to document local patterns of susceptibility, patient profile, and usefulness of screening in postmenopausal patients coming to gynecology outpatient clinics in Pakistan. This will also capture the initial management of PMO in diagnosed patients. The information gathered will serve as a foundation for developing national guidelines on screening and management of PMO in Pakistan.

Completed

Looking for future studies?

Notify Me

Key information

Age range

50 year and older

Sex eligibility

Female

Study type

Observational

Primary location

Islamabad, Pakistan

Loading trial locations.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Postmenopausal women
  • Age 50 years or greater

Exclusion criteria

  • Previously diagnosed osteoporosis, or receiving treatment for osteoporosis

Treatment and study plan

Primary outcomes

  1. Percentage of patients diagnosed with PMO based upon dual-energy X-ray absorptiometry (DXA) results

    Time frame: Up to 12 months

Secondary outcomes

  1. Use of various PMO treatment modalities

    Time frame: Up to 12 months

Sponsors and collaborators

Lead sponsor

Hoffmann-La Roche

Industry

Registry information

Official study title

Registry on Post Menopausal Osteoporosis in Gynecology Setting in Pakistan (REPOSE)

Important dates

Study start
2010
Primary completion
2011
Study completion
2011
First posted
Apr 21, 2015
Registry last updated
Nov 2, 2016

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.